Subcutaneous treprostinil for the treatment of severe, non-operable chronic thromboembolic pulmonary hypertension: a randomized, double-blind, controlled study (CTREPH) | Zendy

AI Assistant Blog Pricing

Subcutaneous treprostinil for the treatment of severe, non-operable chronic thromboembolic pulmonary hypertension: a randomized, double-blind, controlled study (CTREPH)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.